- Home
- ATNM vs PMEC Comparison
ATNM vs PMEC Comparison
Compare ATNM & PMEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNM
- PMEC
- Stock Information
- Founded
- ATNM 2000
- PMEC 1984
- Country
- ATNM United States
- PMEC Singapore
- Employees
- ATNM N/A
- PMEC N/A
- Industry
- ATNM Biotechnology: Pharmaceutical Preparations
- PMEC
- Sector
- ATNM Health Care
- PMEC
- Exchange
- ATNM Nasdaq
- PMEC Nasdaq
- Market Cap
- ATNM 50.2M
- PMEC 56.9M
- IPO Year
- ATNM N/A
- PMEC 2023
- Fundamental
- Price
- ATNM $1.58
- PMEC $1.73
- Analyst Decision
- ATNM Strong Buy
- PMEC
- Analyst Count
- ATNM 2
- PMEC 0
- Target Price
- ATNM $4.50
- PMEC N/A
- AVG Volume (30 Days)
- ATNM 116.8K
- PMEC 34.5K
- Earning Date
- ATNM 11-13-2025
- PMEC 01-01-0001
- Dividend Yield
- ATNM N/A
- PMEC N/A
- EPS Growth
- ATNM N/A
- PMEC N/A
- EPS
- ATNM N/A
- PMEC N/A
- Revenue
- ATNM N/A
- PMEC $74,349,000.00
- Revenue This Year
- ATNM N/A
- PMEC N/A
- Revenue Next Year
- ATNM N/A
- PMEC N/A
- P/E Ratio
- ATNM N/A
- PMEC N/A
- Revenue Growth
- ATNM N/A
- PMEC 2.52
- 52 Week Low
- ATNM $1.03
- PMEC $0.54
- 52 Week High
- ATNM $2.41
- PMEC $1.89
- Technical
- Relative Strength Index (RSI)
- ATNM 42.17
- PMEC 46.48
- Support Level
- ATNM $1.56
- PMEC $1.61
- Resistance Level
- ATNM $1.64
- PMEC $1.80
- Average True Range (ATR)
- ATNM 0.06
- PMEC 0.07
- MACD
- ATNM -0.01
- PMEC -0.02
- Stochastic Oscillator
- ATNM 6.67
- PMEC 44.00
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About PMEC Primech Holdings Ltd.
Primech Holdings Ltd is a technology-driven facilities services provider in the public and private sectors operating mainly in Singapore. The services offered by the company include Facilities services, Stewarding services, Cleaning services to offices, Cleaning services to homes, and Cleaning Supplies.